LOURIA HAYON IGAL (Chief Technology Officer) reported 1 transaction at RAPHAEL PHARMACEUTICAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/25/2024ACC: 0001213900-24-025519
DirectorOfficer· Chief Technology Officer
Since Sep 2021
0.00
Net shares
Net seller
$10.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
999K acquired · 999K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+999K
Price / share
$0.01
Trade value
$9.99K
% of position
New position
8/29/2023
0.00→999K
Total
Net shares
+999K
Net value
$9.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/29/2023 | X · X | +999K | $0.01 | $9.99K | New position | 0.00 | 999K |
| Total | +999K | $9.99K | ||||||
Derivative Transactions1
Warrants to purchase Common Stock
Direct
Converts to
Common Stock
999K shares
Shares
−999K
Strike price
0.01
Held after
0.00
Exercisable
—
8/29/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to purchase Common Stock Direct | Common Stock999K shares | 8/29/2023 | X · X | −999K | 0.01 | — | 0.00 |